Aditxt Market Capitalization from 2010 to 2025
| ADTX Stock | USD 6.41 0.44 6.42% |
Check Aditxt financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aditxt's main balance sheet or income statement drivers, such as Interest Expense of 7.7 M, Selling General Administrative of 11.9 M or Tax Provision of 0.0, as well as many indicators such as Price To Sales Ratio of 8.5 M, Dividend Yield of 0.0 or PTB Ratio of 295 K. Aditxt financial statements analysis is a perfect complement when working with Aditxt Valuation or Volatility modules.
Aditxt | Market Capitalization |
Latest Aditxt's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Aditxt Inc over the last few years. It is Aditxt's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aditxt's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 7.18 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Aditxt Market Capitalization Regression Statistics
| Arithmetic Mean | Huge | |
| Geometric Mean | Huge | |
| Coefficient Of Variation | 32.31 | |
| Mean Deviation | Huge | |
| Median | Huge | |
| Standard Deviation | Huge | |
| Sample Variance | 329950994995857T | |
| Range | 41.9T | |
| R-Value | (0.72) | |
| Mean Square Error | 169959979904399.5T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | (2,749,237,972,643) | |
| Total Sum of Squares | 4949264924937854T |
Aditxt Market Capitalization History
About Aditxt Financial Statements
Aditxt investors use historical fundamental indicators, such as Aditxt's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Aditxt. Please read more on our technical analysis and fundamental analysis pages.
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Aditxt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 58 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Aditxt Stock Analysis
When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.